Chondroitin by fermentation by HTL

Chondroitin by fermentation by HTL
Product Description

While most Chondroitin sulfate on the market is of animal origin, HTL is developing a new source of Chondroitin of non-animal origin with the use of fermentation. Chondroitin sulfate can then be obtained by sulfation. 

Characteristics and benefits of Chondroitin by fermentation: 

  • absence of animal traces and prion contamination
  • helps protect endangered animal species
  • access to a Chondroitin with higher molecular weight, which opens up the potential for new applications
HTL can produce Chondroitin with a Molecular Weight around 50 kDa (Chondroitin Sulfate) or 400 kDa (non-sulfated Chondroitin). HTL is your partner for the development of tailor-made functionalized Chondroitin derivatives such as Chondroitin sulfate.

Today’s applications: rheumatology, ophthalmology.
Potential applications: tissue engineering, oncology, anti-inflammatory and anti-viral potential

HTL

  • FR
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
Specifications
  • Selling Points
    Quality Service
  • Supplied from
    France

HTL

  • FR
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator

More Products from HTL (3)

  • Hyaluronan / hyaluronic acid by HTL

    Product Hyaluronan / hyaluronic acid by HTL

    Hyaluronic acid, also known as Hyaluronan, is a biopolymer that is naturally present in the human body. It has been used for many years as a raw material or ingredient for medical products in various fields including ophthalmology, orthopaedics and dermatology.
    HTL produces injectable grade Hyaluro...
  • Heparosan by HTL

    Product Heparosan by HTL

    HTL is developing Heparosan, a promising raw material for the design of innovative medical devices. Under license, HTL will be the sole producer of medical grade, high molecular weight Heparosan by fermentation (20 kDa to 2MDa). Safe for use in humans, Heparosan is an endogenous GlycosAminoGlycan with...
  • Functionalized GlycosAminoGlycan Derivatives

    Product Functionalized GlycosAminoGlycan Derivatives

    HTL offers the tailor-made development of functionalized derivatives of Glycosaminoglycans, such as modified Hyaluronic Acid, Heparosan and Chondroitin. Developing new functionalities by chemical modification allows the optimization of existing uses of these biopolymers, but also opens opportunities for n...

HTL resources (3)

  • News HTL launches a new, cutting-edge bioproduction unit for pharmaceutical-grade biopolymers

    HTL is a French biotechnology company and industrial player that has become a world leader in the development and production of pharmaceutical-grade biopolymers. Thanks to this new investment of 50 million euros, HTL will more than double its production capacity, allowing it to accelerate its international development and become the world's largest producer of pharmaceutical-grade hyaluronic acid. Biopolymers produced by this unit will enable an increasing number of leading companies in the pharmaceutical and medical devices sectors to offer innovative therapeutic solutions to their patients worldwide.
  • Brochure HTL corporate brochure

    HYALURONIC ACID & BIOPOLYMERS FOR PREMIUM MEDICAL PRODUCTS

    Beyond, together.
  • Video HTL video - Beyond, Together.

    All over the world, men and women are living longer. They aspire to better health, greater well-being, and living life to its fullest, whatever their age. Since its creation, HTL’s mission has been to invent innovative solutions to meet the health challenges of the future. And because the best remedies are those that reside in us, we have focused our research on the biopolymers naturally existing in the human body...